Proceedings: Pharmacological examinations by an ulcus inhibiting agent (L-S 519).
D000818:Animals; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002217:Carbachol / Q000494:pharmacology; D003543:Cysteamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004381:Duodenal Ulcer / Q000139:chemically induced / Q000188:drug therapy; D005755:Gastrins / Q000494:pharmacology; D010437:Peptic Ulcer / Q000139:chemically induced / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D051381:Rats; D013552:Swine
D001570:Benzodiazepinones; D005755:Gastrins; D010879:Piperazines; D003543:Cysteamine; D002217:Carbachol